Kensana Health Acquires ABcann Medicinals Napanee Facility From MediPharm Labs for $5.5M
December 17, 2024
MediPharm Labs entered into a share purchase agreement to sell its Napanee, Ontario facility to Kensana Health for $5.5 million in cash. The deal will transfer all shares of MediPharm’s wholly owned subsidiary ABcann Medicinals Inc., including the Napanee Facility’s license and related building, land, and equipment.
- Buyers
- Kensana Health Inc.
- Targets
- ABcann Medicinals Inc., MediPharm Labs Napanee Facility
- Sellers
- MediPharm Labs Corp.
- Industry
- Healthcare Services
- Location
- Ontario, Canada
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.